1-Minute Pearls/Pitfalls for the Clinician

Area of Science:

• Nephrology
• Hepatology
• Hematology

Background:

• High-risk membranous nephropathy presents complex management challenges, including venous thromboembolism (VTE) risk.
• Hepatitis B virus (HBV) reactivation is a significant concern in patients requiring immunosuppressive therapy.

Purpose of the Study:

• To outline optimal VTE management strategies for patients with high-risk membranous nephropathy.
• To provide guidance on the care of hepatitis B core antibody-positive patients initiating immunosuppressive therapy, focusing on preventing HBV reactivation.

Main Methods:

• Review of current literature and clinical guidelines on VTE management in nephrotic syndromes.
• Analysis of established protocols for HBV screening and prophylaxis in immunosuppressed populations.

Main Results:

• Specific anticoagulation considerations for VTE in membranous nephropathy patients are discussed.
• Recommendations for antiviral prophylaxis and monitoring in hepatitis B core antibody-positive patients undergoing immunosuppression are presented.

Conclusions:

• Effective VTE prophylaxis and treatment are crucial in high-risk membranous nephropathy.
• Proactive management of hepatitis B core antibody-positive status is essential to ensure safe immunosuppressive therapy initiation and continuation.